Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

UCB patents new inhibitors of PI3K isoforms

Oct. 7, 2010

Viralytics advances phase I trial of coxsackievirus A21

Oct. 7, 2010

FDA provides guidance to Celsion for ThermoDox NDA

Oct. 7, 2010

Teva provides update on status of BLA for Neutroval in neutropenia

Oct. 6, 2010

Ambit Biosciences presents new inhibitors of JAK2 and JAK3

Oct. 6, 2010

Phase II data reported on Cevira in patients with mild cervical abnormalities

Oct. 6, 2010

Cellceutix completes toxicity studies of anticancer agent Kevetrin

Oct. 5, 2010

Barcelona researchers claim new apoptosis inducers

Oct. 5, 2010

Eisai and Anaeropharma partner to discover Bifidobacterium-delivered anticancer agents

Oct. 5, 2010

Global marketing rights to Caelyx to transition from Merck & Co. to Janssen

Oct. 5, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...